Locations
England, UK · London, UK · South West England, UK · Mile End, London, UK · Kingston Vale, London SW15, UK
industry
Biotechnology
Size
51 - 200 employees
Stage
Series B
founded in
2012
Labgenius Therapeutics ("Labgenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVA™, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation, and synthetic biology. While EVA™ is both modality and format-agnostic, Labgenius' internal pipeline is focused on the development of selectivity-enhanced antibodies for the treatment of solid tumors. The company's novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.
Something looks off?On-site & Remote